Clinical characteristics and homology analysis of Staphylococcus aureus from would infection at a tertiary hospital in southern Zhejiang, China

[1]  Jiachang Cai,et al.  Clinical characteristics of and risk factors for secondary bloodstream infection after pneumonia among patients infected with methicillin-resistant Staphylococcus aureus , 2022, Heliyon.

[2]  K. Toyoda,et al.  Clinical Characteristics and Factors Related to Infection with SCCmec Type II and IV Methicillin-Resistant Staphylococcus aureus in a Japanese Secondary Care Facility: A Single-Center Retrospective Study. , 2022, Journal of global antimicrobial resistance.

[3]  C. Kowalewski,et al.  Molecular Mechanisms of Drug Resistance in Staphylococcus aureus , 2022, International journal of molecular sciences.

[4]  Ying Sun,et al.  The Correlation Between Biofilm-Forming Ability of Community-Acquired Methicillin-Resistant Staphylococcus aureus Isolated from the Respiratory Tract and Clinical Characteristics in Children , 2022, Infection and drug resistance.

[5]  Manjyot Kaur Chug,et al.  Smartphone compatible nitric oxide releasing insert to prevent catheter-associated infections. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[6]  K. Tateda,et al.  Changes in the Genotypic Characteristics of Community-Acquired Methicillin-Resistant Staphylococcus aureus Collected in 244 Medical Facilities in Japan between 2010 and 2018: a Nationwide Surveillance , 2022, Microbiology spectrum.

[7]  T. Msadek,et al.  Natural transformation allows transfer of SCCmec-mediated methicillin resistance in Staphylococcus aureus biofilms , 2022, Nature Communications.

[8]  Yunsong Yu,et al.  SCCmec amplification as a mechanism for ceftobiprole resistance in clinical MRSA isolates. , 2022, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  F. Huang,et al.  Etiology, clinical features, management, and outcomes of skin and soft tissue infections in hospitalized children: A 10-year review. , 2022, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[10]  F. Aarestrup,et al.  Emergence of methicillin resistance predates the clinical use of antibiotics , 2022, Nature.

[11]  Alan D. Lopez,et al.  Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis , 2022, The Lancet.

[12]  Rhys A. Farrer,et al.  Drivers of methicillin-resistant Staphylococcus aureus (MRSA) lineage replacement in China , 2021, Genome Medicine.

[13]  O. Zishiri,et al.  Genotypic and Phenotypic Characterizations of Methicillin-Resistant Staphylococcus aureus (MRSA) on Frequently Touched Sites from Public Hospitals in South Africa , 2021, International journal of microbiology.

[14]  N. Ohmagari,et al.  Length of stay, hospitalisation costs and in-hospital mortality of methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia in Japan. , 2021, Public health.

[15]  M. Law,et al.  Efficacy and Safety of Intravenous Lincosamide Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia , 2021, Antimicrobial agents and chemotherapy.

[16]  S. Cosgrove,et al.  Decolonization of Staphylococcus aureus. , 2020, Infectious disease clinics of North America.

[17]  S. Monecke,et al.  Multiple distinct outbreaks of Panton-Valentine leukocidin (PVL)-positive community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in Ireland investigated by whole-genome sequencing. , 2020, The Journal of hospital infection.

[18]  R. Kishony,et al.  Ubiquitous selection for mecA in community-associated MRSA across diverse chemical environments , 2020, Nature Communications.

[19]  M. Galdiero,et al.  Methicillin-resistant Staphylococcus aureus: epidemiology and antimicrobial susceptibility experiences from the University Hospital ‘Luigi Vanvitelli’ of Naples , 2020, Pathogens and global health.

[20]  Masao Tanaka,et al.  Mortality related to drug-resistant organisms in surgical sepsis-3: an 8-year time trend study using sequential organ failure assessment scores , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[21]  L. Hsu,et al.  Comparative epidemiology and factors associated with major healthcare-associated methicillin-resistant Staphylococcus aureus clones among interconnected acute, intermediate- and long-term healthcare facilities in Singapore. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  Qianqian Huang,et al.  Point-prevalence surveys of hospital-acquired infections in a Chinese cancer hospital: From 2014 to 2018. , 2020, Journal of infection and public health.

[23]  Hengjin Dong,et al.  Clinical and economic impact of methicillin-resistant Staphylococcus aureus: a multicentre study in China , 2020, Scientific Reports.

[24]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[25]  A. Richardson,et al.  The Toxin-Antitoxin MazEF Drives Staphylococcus aureus Biofilm Formation, Antibiotic Tolerance, and Chronic Infection , 2019, mBio.

[26]  F. Hu,et al.  Resistance reported from China antimicrobial surveillance network (CHINET) in 2018 , 2019, European Journal of Clinical Microbiology & Infectious Diseases.

[27]  John Jernigan,et al.  Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States , 2019, MMWR. Morbidity and mortality weekly report.

[28]  B. Sharma-Kuinkel,et al.  Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research , 2019, Nature Reviews Microbiology.

[29]  C. Wolz,et al.  Methicillin-resistant Staphylococcus aureus alters cell wall glycosylation to evade immunity , 2018, Nature.

[30]  W. Rodriguez-Cintron,et al.  Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  K. Zou,et al.  A multi-center nested case-control study on hospitalization costs and length of stay due to healthcare-associated infection , 2018, Antimicrobial Resistance & Infection Control.

[32]  S. Harbarth,et al.  Methicillin-resistant Staphylococcus aureus , 2018, Nature Reviews Disease Primers.

[33]  H. Nakaminami,et al.  Change in genotype of methicillin-resistant Staphylococcus aureus (MRSA) affects the antibiogram of hospital-acquired MRSA. , 2018, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[34]  M. Ouellette,et al.  Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. , 2017, The Lancet. Infectious diseases.

[35]  L. Zeng,et al.  Drug-resistance dynamics of Staphylococcus aureus between 2008 and 2014 at a tertiary teaching hospital, Jiangxi Province, China , 2017, BMC Infectious Diseases.

[36]  H. Samadi kafil,et al.  Contribution of mexAB-oprM and mexXY (-oprA) efflux operons in antibiotic resistance of clinical Pseudomonas aeruginosa isolates in Tabriz, Iran. , 2016, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[37]  D. Blackhurst,et al.  Electronic hand hygiene monitoring as a tool for reducing health care-associated methicillin-resistant Staphylococcus aureus infection. , 2016, American journal of infection control.

[38]  Jason A Inzana,et al.  Biomaterials approaches to treating implant-associated osteomyelitis. , 2016, Biomaterials.

[39]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[40]  Adil Rafiq Rather,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) , 2015 .

[41]  Vance G. Fowler,et al.  Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management , 2015, Clinical Microbiology Reviews.

[42]  Gajanand Sharma,et al.  Phospholipid structured microemulsion as effective carrier system with potential in methicillin sensitive Staphylococcus aureus (MSSA) involved burn wound infection , 2015, Journal of drug targeting.

[43]  J. Reilly,et al.  Screening for meticillin resistant Staphylococcus aureus (MRSA): who, when, and how? , 2014, BMJ : British Medical Journal.

[44]  J. Decruyenaere,et al.  Microbial etiology and antimicrobial resistance in healthcare-associated versus community-acquired and hospital-acquired bloodstream infection in a tertiary care hospital. , 2013, Diagnostic microbiology and infectious disease.

[45]  Z. Bhutta,et al.  Umbilical cord antiseptics for preventing sepsis and death among newborns. , 2013, The Cochrane database of systematic reviews.

[46]  K. Inokuchi,et al.  Mobile Genetic Element SCCmec-encoded psm-mec RNA Suppresses Translation of agrA and Attenuates MRSA Virulence , 2013, PLoS pathogens.

[47]  J. Otter,et al.  The Role Played by Contaminated Surfaces in the Transmission of Nosocomial Pathogens , 2011, Infection Control & Hospital Epidemiology.

[48]  G. Ippolito,et al.  Methicillin-resistant Staphylococcus aureus: the superbug. , 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[49]  G. Sensabaugh,et al.  Widespread Skin and Soft-Tissue Infections Due to Two Methicillin-Resistant Staphylococcus aureus Strains Harboring the Genes for Panton-Valentine Leucocidin , 2010, Journal of Clinical Microbiology.

[50]  D. Missiakas,et al.  Staphylococcus aureus synthesizes adenosine to escape host immune responses , 2009, The Journal of experimental medicine.

[51]  Henry F. Chambers,et al.  Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.

[52]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[53]  Atlanta,et al.  Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States , 2007 .

[54]  J. Patel,et al.  Characterization of a Strain of Community-AssociatedMethicillin-Resistant Staphylococcus aureus WidelyDisseminated in the UnitedStates , 2006, Journal of Clinical Microbiology.

[55]  G. Stoddard,et al.  Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci in Rural Communities, Western United States , 2005, Emerging infectious diseases.

[56]  A. L. Darini,et al.  First Report of Vancomycin-Resistant Staphylococci Isolated from Healthy Carriers in Brazil , 2005, Journal of Clinical Microbiology.

[57]  E. Reinoso,et al.  RAPD-PCR analysis of Staphylococcus aureus strains isolated from bovine and human hosts. , 2004, Microbiological research.

[58]  G. Sensabaugh,et al.  Widespread Skin and Soft-Tissue Infections Due to Two Methicillin-Resistant Staphylococcus aureus Strains Harboring the Genes for Panton-Valentine Leucocidin , 2004, Journal of Clinical Microbiology.

[59]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[60]  B. Yangco,et al.  CDC definitions for nosocomial infections. , 1989, American journal of infection control.

[61]  J M Hughes,et al.  CDC definitions for nosocomial infections, 1988. , 1988, American journal of infection control.

[62]  M. Rupp,et al.  Exebacase for patients with Staphylococcus aureus bloodstream infection and endocarditis , 2020 .

[63]  A. Kumar.  Invasive Methicillin-Resistant Staphylococcus aureus Infections in the United States , 2008 .

[64]  Clinical,et al.  Performance standards for antimicrobial disk susceptibility tests : approved standard , 2006 .

[65]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..